Ali says this is simply good news for people with type 2 diabetes, overweight, or obesity who also have depression or anxiety
Insurance Coverage and Prescribing Guidelines GLP-1 medications such as Ozempic, Wegovy, and Mounjaro are now approved for long-term use in maintaining weight loss after an initial reduction phase
However, follow-up research published in JAMA 2024 showed many patients regained a significant portion of the weight after stopping the drug
Its program focuses on convenience, with a simple onboarding process, provider oversight, and flat pricing that covers any dose, free home delivery, and no cancellation fees
Key takeaways Reduced effectiveness: While microdosing your GLP-1 might help ease temporary side effects like nausea, it also makes the medication less effective
Typically, those who should avoid GLP-1s are those with: A personal or family history of certain thyroid cancers Multiple endocrine neoplasia syndrome type 2 A history of pancreatitis Severe gastroparesis (delayed stomach emptying) Pregnancy or plans to become pregnant Additionally, if you have a history of eating disorders, severe depression or unrealistic weight loss expectations, its important to address these concerns with your physician before considering medication
